Loading...
Docoh

Gemini Therapeutics (GMTX)

Gemini Therapeutics is a clinical stage precision medicine company developing novel therapeutic compounds to treat genetically de?ned age-related macular degeneration (AMD). Gemini's lead candidate, GEM103, is a recombinant form of the human complement factor H protein (CFH), and is designed to address both complement hyperactivity and restore retinal health in patients with AMD. GEM103 is currently in a Phase 2a trial in dry AMD patients with a CFH risk variant. The company has generated a rich pipeline including recombinant proteins, gene therapies, and monoclonal antibodies.

GMTX stock data

Calendar

11 Aug 22
15 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 108.66M 108.66M 108.66M 108.66M 108.66M 108.66M
Cash burn (monthly) 3.58M 4.93M 2.41M 4.88M 3.17M 4.55M
Cash used (since last report) 5.46M 7.52M 3.68M 7.45M 4.83M 6.94M
Cash remaining 103.2M 101.14M 104.98M 101.21M 103.83M 101.72M
Runway (months of cash) 28.9 20.5 43.5 20.7 32.8 22.4

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
31 May 22 Brian Piekos Common Stock Grant Acquire A No No 1.09 9,960 10.86K 17,615
13 Apr 22 Braden Michael Leonard Common Stock Buy Acquire P Yes No 1.5206 191,769 291.6K 5,000,000
12 Apr 22 Braden Michael Leonard Common Stock Buy Acquire P Yes No 1.4243 203,744 290.19K 4,808,231
12 Apr 22 Braden Michael Leonard Common Stock Buy Acquire P No No 1.365 55,000 75.08K 270,000
11 Apr 22 Braden Michael Leonard Common Stock Buy Acquire P Yes No 1.35 504,487 681.06K 4,604,487
13 Jan 22 Brian Piekos RSU Common Stock Grant Acquire A No No 0 280,876 0 280,876
3 Jan 22 Gemayel Georges Stock Option Common Stock Grant Acquire A No No 3.08 793,274 2.44M 793,274
99.1% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 61 66 -7.6%
Opened positions 9 12 -25.0%
Closed positions 14 14
Increased positions 13 16 -18.8%
Reduced positions 23 18 +27.8%
13F shares Current Prev Q Change
Total value 42.63M 93.8M -54.6%
Total shares 42.84M 44.3M -3.3%
Total puts 0 15.7K EXIT
Total calls 19.5K 69.1K -71.8%
Total put/call ratio 0.2
Largest owners Shares Value Change
Orbimed Advisors 5.83M $8.1M 0.0%
Atlas Venture Life Science Advisors 5.25M $7.3M 0.0%
FS Development 4.87M $0 0.0%
Atlas Venture Fund X 4.02M $0 0.0%
Lightstone Ventures 3.18M $0 0.0%
Foresite Capital Management V 2.44M $3.39M 0.0%
Foresite Capital Opportunity Management V 2.44M $3.39M 0.0%
Suvretta Capital Management 2.37M $3.3M 0.0%
BML Investment Partners 2.3M $3.06M NEW
BLK Blackrock 1.3M $1.81M +3.5%
Largest transactions Shares Bought/sold Change
BML Investment Partners 2.3M +2.3M NEW
FMR 397.35K -1.49M -78.9%
BEN Franklin Resources 1.07M -1.44M -57.3%
Alyeska Investment 0 -635.69K EXIT
JS Capital Management 0 -474.46K EXIT
Renaissance Technologies 351.1K +339.2K +2850.4%
Vanguard 740.8K -327.85K -30.7%
Adage Capital Partners GP, L.L.C. 882.61K +200K +29.3%
Allspring Global Investments 115.21K +98.96K +608.7%
Marquette Asset Management 66.27K +66.27K NEW

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
Coll freshman Bad
New words: acquiror, analogy, ARPA, assumption, attention, Biden, certainty, challenging, commensurate, conflict, consent, contemplated, coverage, create, customary, CVR, decline, difficult, Disc, discharging, discourage, dissolution, divert, diverted, entertain, exacerbated, extremely, facilitate, failure, fiduciary, formula, fourth, gem, Gemstone, guarantee, harm, IAS, lengthy, liable, lieu, listing, lose, monetizing, motivate, occurrence, partner, pendency, pending, percentage, prevent, proposal, proposed, Putative, quotient, rapidly, recommend, refundable, Rescue, resolved, respond, retention, run, satisfaction, short, Similarly, Social, solicit, split, unanimously, unexpected, upward, view, waiver, winding
Removed: Chief, landlord, liquidity, maximize, obligation, performance, retaining, shorter, update